CI
NVO

Corient IA’s Novo Nordisk NVO Stock Holding History

Corient IA’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$170K Hold
4,630
– – 0.16% 225
2025
Q4 		$236K Sell
4,630
-2,370
-34% -$121K 0.22% 181
2025
Q3 		$388K Sell
7,000
-1,400
-17% -$81.9K 0.29% 134
2025
Q2 		$580K Hold
8,400
– – 0.34% 94
2025
Q1 		$583K Buy
+8,400
New +$694K 0.41% 78

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Corient IA's NVO Position: Q1 2026 in Review

Corient IA held its Novo Nordisk (NVO) position steady in Q1 2026 at 4,630 shares worth $170K. The position accounts for 0.16% of the portfolio, ranked #225.

Corient IA first reported a position in NVO in Q1 2025 and has held it in 5 quarters since. The position peaked at $583K in Q1 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Corient IA held 4,630 shares of Novo Nordisk worth $170K as of Q1 2026.
  • Corient IA left its Novo Nordisk share count unchanged in Q1 2026.
  • Novo Nordisk made up 0.16% of Corient IA's portfolio in Q1 2026, its #225 holding.
  • Corient IA first reported a position in Novo Nordisk in Q1 2025 and has held it in 5 quarters since.
  • Corient IA's Novo Nordisk position peaked at $583K in Q1 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Corient IA's 13F filing for Q1 2026, filed 14 May 2026.